Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026

Eli Lilly is further strengthening its position in immunology with its 13th acquisition of the year, paying up to $2.875 billion for Merida Biosciences and its asset in the increasingly popular subfields ...